Market and IP review
5products studied
Define the products
We built a large dataset on the five products, covering both the market and the patent position.
Case Study · Competitive Intelligence
Analyzing the competition before a generics launch.
A European pharmaceutical company wanted to beat rivals to market with new combined generic drugs and needed to know who else was developing them. We studied the market and the IP and helped the client decide which products to push forward.
The Client
The client is a European pharmaceutical company planning to bring five new combined generic drugs to market ahead of its rivals. It engaged Prescouter through a Research Support Service project to manage risk and guide its product development strategy with competitive intelligence.
The Challenge
Be early to market.
Know who else is in the race.
Prescouter was asked to find out whether any competitors were developing the same five products, so the client could decide which ones to push forward.
-
Who is developing
Generic drug makers
Which companies might be developing the same products.
-
What is protected
Intellectual property
Patents that could stand in the way of each product.
-
Where they sell
Entry into Europe
Whether these products could reach the European market in the future.
Our Approach
Building a full market and IP view of five products.
Competitor analysis
125generic drug makers analyzed
Check every rival
We analyzed 125 generic drug makers in depth to see whether these products were in development.
Market entry
Europefuture market entry
Look ahead
The team also assessed whether any of these products were likely to enter the European market in the future.
The Outcome
A clear field for the client’s products.
Prescouter showed that there was no major IP or commercial activity around these specific products. The client used the findings to decide whether to manufacture them and to set next steps in its production strategy and pipeline.
-
IP
No major patent barriers
No major intellectual property found around the five products.
-
Competition
No major commercial rivals
No major commercial activity found among 125 generic drug makers.
-
Pipeline
Clear next steps
Findings that guided the client’s production strategy and pipeline.
Being early to market only pays if no one else is close behind. Checking patents and rivals early lets you make that call with evidence.
Let’s Talk
Are your next products really ahead of the field?
Build your pipeline decisions on a clear view of competitors, patents, and market entry. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]